R&D Separating scientific risk assessment & consumer perception In pharmaceutical development, conclusions are built on structured laboratory investigations and reproducible data, rather than simple classification.
Patients Strengthening safety: The critical role of reliable labellin... Learn more about the important role that labelling plays within pharmaceutical labelling and across blood transfusions.
Digital The future of pharmacovigilance – beginning the shift to AI-... In 2023, the pharmaceutical industry saw a surge in innovation.
R&D Integrating pharmaceutical functions: Using quality insights... As the life sciences field becomes more complex, it is apparent that many aspects of product quality and safety processes are inextricably linked
Partner Content Partner Content How automatization keeps drug safety in war-torn Ukraine Unbreakable digital solution for drug safety teams
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.